β-Core fragment (β-core/UGF/UGP), a tumor marker: A 7-year report

Gynecologic Oncology

Volumn 60, Issue 2, 1996, Pages 264-270

  Cole, Laurence A ^a   Tanaka, Akira ^a   Kim, Goo Sang ^a   Park, Sang Yoon ^b   Koh, Min Whan ^a   Schwartz, Peter E ^a   Chambers, Joseph T ^a   Nam, Joo Hyun ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Korea Cancer Center Hospital   (South Korea)

^c University of Ulsan   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; TUMOR MARKER;

ADVANCED CANCER; ARTICLE; BETA CHAIN; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; OVARY CANCER; PRIORITY JOURNAL; REFERENCE VALUE; UTERINE CERVIX CANCER;

EID: 0030046088     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0036     Document Type: Article

References (38)

1. Birken, S., Armstrong, E. G., Kolks, M. A. G., Cole, L. A., Agosto, G. M., Krichevsky, A., Vaitukaitis, J. L., and Canfield, R. E. Structure of human chorionic gonadotropin β-subunit core fragment from pregnancy urine, Endocrinology 123, 572-583 (1988).
2. Mathies, D. L., and Diczfalusy, E. Differences in the physical properties of human chorionic gonadotropin extracted from different sources, Int Congr. Ser. Excerpta Med. 170, 34 (1968).
3. Vaitukaitis, J. L. Immunologic and physical characterization of human chorionic gonadotropin (hCG) secreted by tumors, J. Clin. Endocrinol. Metab. 37, 505-514 (1973).
4. Masure, H. R., Jaffee, W. L., Sickel, M. A., Birken, S., Canfield, R. E., and Vaitukaitis, J. L. Characterization of a small molecular size urinary immunoreactive human chorionic gonadotropin (hCG)-like substance produced by normal placental and by hCG-secreting neoplasms, J. Clin. Endocrinol. Metab. 53, 1014-1020 (1981).
5. Cole, L. A., Wong, Y., Latif, M., Chambers, J. T., Chambers, S. K., and Schwartz, P. E. Urinary human chorionic gonadotropin free β-subunit and β-fragment: New markers gynecologic cancers, Cancer Res. 48, 1356-1360 (1988).
6. Cole, L. A., Schwartz, P. E., and Wong, Y. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. I. Sensitivity and specificity, comparison with other markers, Gynecol. Oncol. 31, 82-90 (1988).
7. Wong, Y., Schwartz, P. E., Chambers, J. T., and Cole, L. A. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. II. Initial serial studies, Gynecol. Oncol. 31, 91-100 (1988).
8. Cole, L. A. β-core fragment (β-core, UGP or UGF), Tumor Marker Update 6, 69-75 (1994).
9. Walker, R. P., Crebbin, V. A., Porreca, P., Garrett, D. D., and Weitz, S. Urinary beta-core as a marker for monitoring of ovarian and other gynecological cancer, Proc. 15th Int. Cancer Conf. Hamburg (1990). [Abstract B2.144.09]
10. Tanaka, A., Nam, J. H., Park, S. Y., and Cole, L. A. Urinary β-core a marker of cervical cancer, Proc. 14th Int. Congr. Gynecol. Obstet. Montreal, Canada, (1994). [Abstract 398]
11. Schwartz, P. E., Chambers, J. T., Taylor, K. J., and Cole, L. A., Makuch, R. Urinary gonadotropin fragments, Anticancer Res. 13, 1722-1725 (1993).
12. Ballesta, A. M., Molina, R., Jo, J., and Filella, X. Methodological and technical evaluation of a new tumor marker, UGP. Preliminary results in patients with benign and malignant diseases, Proc. 5th Int. Symp. Biol. Clin. Usefulness Tumor Markers, Barcelona, Spain (1995). [Abstract L35]
13. Maruo, T., et al. (36 authors) Clinical significance of the measurement of urinary hCG beta core fragment in patients with gynecologic malignant tumors, Obstet. Gynecol. Jpn. 7, 1197-1202 (1991).
14. Kinugasa, M., Nishimura, R., Hasegawa, K., Okamura, M., Kimura, A., and Ohtsu, F. Assessment of urinary β-core fragment of hCG as a tumor marker of cervical cancer, Acta Obstet Gynecol Jpn. 44, 188-194 (1992).
15. Tomoda, Y., Kawai, M., Goto, S., Kikkawa, F., Okamoto, T., Furuhashi, Y., Ishizuka, T., Kazeto, S., Kobayashi, I., Hattori, S-E., Kuzuya, K., Ohta, M., Arii, Y., Fujita, Y., and Matsuo, K. Clinical significance of urinary hCG β-core assay in the diagnosis of ovarian and cervical carcinoma, World Obstet Gynecol. 46, 73-78 (1994).
16. Nam, J. H., Cole, L. A., Chambers, J. T., and Schwartz, P. E. Urinary gonadotropin fragment a new tumor marker. I. Assay development and cancer specificity, Gynecol. Oncol. 36, 383-390 (1990).
17. Nam, J. H., Chambers, J. T., Schwartz, P. E., and Cole, L. A. Urinary gonadotropin fragment a new tumor marker. IV. Use in endometrial and uterine cancers, Gynecol. Oncol. 39, 353-357 (1990).
18. Nam, J. H., Chang, K. C., Chambers, J. T., Schwartz, P. E., and Cole, L. A. Urinary gonadotropin fragment a new tumor marker. III. Use in cervical and vulvar cancers, Gynecol. Oncol. 38, 66-70 (1990).
19. deMedeiros, S. F., Amato, F., Matthews, C. D., and Norman, R. J. Comparison of specific immunoassays for detection of the beta-core human chorionic gonadotrophin fragment in body fluids, J. Endocrinol. 135, 161-174 (1992).
20. Alfhan, H., Haglund, C., Roberts, P., and Stenman, U. H. Elevation of free β-subunit of human choriogonadotropin and core β fragment of choriogonadotropin in serum and urine of patients with malignant pancreatic and biliary disease, Cancer Res. 52, 4628-4633 (1992).
21. Neven, P., Iles, R. K., Lee, C. L., Hudson, C. N., Shepherd, J. H., and Chard, T. Urinary chorionic gonadotropin subunits and beta-core in nonpregnant women: A study of benign and malignant gynecologic disorders, Cancer 71, 4124-4130 (1993).
22. Carter, P. G., Iles, R. K., Neven, P., Prys Davis, A., Shepherd, J. H., and Chard, T. The measurement of urinary beta core fragment in conjunction with serum CA125 does not aid the differentiation of malignant from benign pelvic masses, Gynecol. Oncol. 51, 368-371 (1993).
23. Norman, R. J., Buck, R. H., Aktar, B., Mayet, N., and Moodley, J. Detection of a small molecular species of human chorionic gonadotropin in the urine of patients with carcinoma of the cervix and cervical intraepithelial neoplasia: Comparison with other assays for human chorionic gonadotropin and its fragments, Gynecol. Oncol. 37, 254-259 (1990).
24. Alfhan, H., Haglund, C., Roberts, P., and Stenman, U. H. Elevation of free β-subunit of human choriogonadotropin and core β fragment of choriogonadotropin in serum and urine of patients with malignant pancreatic and biliary disease, Cancer Res. 52, 4628-4633 (1992).
25. Yamanaka, N., Kawabata, G., Morisue, K., Hazama, M., and Nishimura, R. Urinary hCG beta-core fragment as a tumor marker for bladder cancer, Jpn. J. Urol. 84, 700-706 (1993).
26. D'Agostino, R. S., Cole, L. A., Ponn, R. B., Stern, H., and Schwartz, P. E. Urinary gonadotropin fragment in patients with lung and esophageal disease, J. Surg. Oncol. 49, 147-150 (1992).
27. Tanaka, J., Takashi, M., Okamura, K., Shimochi, T., Miyake, K., and Yamasaki, H. Significance of hCGβ-core fragment in kidney lesions and urinary tract and bladder cancer, Proc. 12th Meeting Tumor Marker Assoc. Osaka, Japan (1992). [Abstract C-31]
28. Chen, Y., Canfield, R. E., Flaster, E., and O'Connor, J. Urinary hCG expression in lung cancer, Proc. Serono Symp. Glycoprotein Hormones, Santa Barbara, CA (1993). [Abstract 11]
29. McGill, J., Cole, L. A., Nam, J., Thornson, A., Christensen, M., Mailliard, J., Chun, M., Wilwerding, M., and Boman, B. Urinary gonadotropin fragment (UGF): A potential "marker" of colorectal cancer, J. Tumor Marker Oncol. 5, 175-177 (1990).
30. Carter, P. G., Iles, R. K., Neven, P., Ind, T. E. J., Shepherd, J. H., and Chard, T. The prognostic significance of urinary β-core fragment in premenopause women with carcinoma of the cervix, Gynecol. Oncol. 55, 271-276 (1994).
31. Kardana, A., Taylor, M. E., Southall, P. J., Boxer, G. M., Rowan, A. J., and Bagshawe, K. D. Urinary gonadotrophin peptide - Isolation and purification, and its immunohistochemical distribution in normal and neoplastic tissues, Br. J. Cancer. 58, 281-286 (1988).
32. Kliman, H. J., Less, K. S., Meaddough, E. L., and Cole, L. A. hCG degradation in the human chorionic villous core, Proc. Serono Symp Glycoprotein Hormones Santa Barbara, CA (1993). [Abstract]
33. Kardana, A., and Cole, L. A. Human chorionic gonadotropin β-subunit nicking enzymes in pregnancy and cancer patient serum, J. Clin. Endocrinol. Metab. 79, 761-767 (1994).
34. Wehmann, R. E., Blithe, D. L., Akar, A. H., and Nisula, B. C. Disparity between beta-core levels in pregnancy urine and serum: Implications for the origin of urinary beta-core, J. Clin. Endocrinol. Metab. 70, 371-378 (1990).
35. Wehmann, R. E., Blithe, D. L., Flack, M. R., and Nisula, B. C. Metabolic clearance rate and urinary clearance of purified beta-core, J. Clin. Endocrinol. Metab. 69, 510-517 (1989).
36. Schwartz, P. E., Chambers, S. K., Chambers, J. T., Guttman, J. G., Katopodis, N., and Foemmel, R. Circulating tumor markers in the monitoring of gynecologic malignancies, Cancer 60, 353 (1987).
37. Plebani, M., Navaglia, G., Baccelli, L., Polonio, S., Lazzari, F., and Marchetti, M. UGP collection of specimens and cut off levels, J. Clin. Lab. Anal. Inst., in press (1995).
38. Ngan, H. Y. S., Yeung, W. S. B., Cheng, G. T. S., Wong, L. C., De Madeiros, S. F., Norman, R. J., and Ma, H-K. Problems in the use of urinary hCG β-core as a tumor marker in gynecological cancer, Int. J. Gynecol. Cancer 5, 15-19 (1995).